I will pick up on a couple of strands. I agree that it is right to have at centre stage of the discussion the whole practice and concept of balance as well as proportionality. I urge members to continue to do that.
I am always passionate about making international comparisons, but I am equally keen that we remember that we are Scotland—we are not England, Austria or Australia. We know ourselves pretty well, and we spent a lot of time crafting a narrative around the kind of politics and institutions that we wanted to have in Scotland. A lot of what I have read in the submissions talks about a different political system and culture from the ones that I know and recognise. We have to be extremely careful about carrying that across.
10:30
Returning to some of the points that Robin McAlpine made, I think that the last way in which to build trust in politicians and the political process is to peddle what I regard as conspiracy theories about all these evil forces that exist and cause-and-effect relationships between what politicians do and the laws that they vote for. All of that is absolute nonsense.
When I was invited to come to the committee, I was asked to reflect on my experiences as an MSP and a minister. If I can have a minute or two, convener, it might be useful to share a couple of thoughts that I have in that regard.
Drugs companies have been mentioned a couple of times. It is important that we do not just do the good-guy, bad-guy thing, so I will reflect on some things that I got wrong in the past. When I was the Minister for Health and Community Care, I never met anyone in the pharmaceutical industry. I accepted the advice of my officials that it was not a good thing to do or to be seen to do, and that, because of the big commercial interests that were involved, it would not play very well so it was best to let enterprise ministers meet those guys. I think that that was wrong.
Some health ministers have held to that view but, as democracy has matured or practices have changed, health ministers have started to meet people from the pharmaceutical industry, as they should. We desperately need to work with the pharmaceutical industry to ensure that patients get the drugs and treatments that they need and deserve. We must ensure that the research and development can be supported and that the companies work alongside our universities and so on.
I got that decision wrong, but I think that it remains the default position in the Parliament. People still think, “Oh, these commercial interests are big, bad and dangerous and we’d better not be seen in the same room as them.”
Thinking about how we work together is the right thing to do. It is an insult to the intelligence of politicians to suggest that, just because information is submitted to them from big commercial organisations, either directly or through paid lobbyists, there will be a cause-and-effect relationship whereby they will roll over and go along with that view. It is much more demeaning for this institution when members stand up and speak in debates and the public can tell that they are not well informed and have not listened to a range of views, thought about how the industry works or whatever.
I would like to give one other example, briefly.